What does HB 167 mean for Utah?
The bill wouldn’t legalize psilocybin which is designated as a Schedule I drug. The Bill would authorize a task force to weigh the potential benefits with the potential dangers of legalization or decriminalization.
The group would meet and provide recommendations on:
- specific types and symptoms of mental illness for which the psychotherapy drug could be used as a treatment option;
- appropriate administration and dosage;
- any license or credential requirement for individuals administering said drugs;
- training that could be helpful for administers of the drug;
- the frequency at which psychotherapy drug may be used;
- any procedures to obtain, store, and monitor the use of the drugs;
- safety requirements and procedures for data tracking, and more.
Psychotherapy Drug Task Force
The task force consists of experts in fields of psychiatry, psychology, pharmacology, neuroscience, mental health, trauma focused therapy, and addiction medicine. It also includes representatives from Utah Medical Association, a Utah hospital, and patient advocacy groups.
Supporting Medical Research
Medical Psilocybin Publications and Resources